Precision Marketing for Precision Medicine: A New Era (Part 2)

🔬 Welcome to the OUTCOMES Podcast, where marketing meets healthcare and biopharma. Part 2 of this episode, "Precision Marketing for Precision Medicine: A New Era," is an in-depth conversation with David Hubbell, Director of Strategy at emagineHealth. Our focus is on the paradigm shift happening in the healthcare and biopharma sectors—personalized medicine. And trust us, it's not just about science but also how we market it. 🎯

🌐 Topics Discussed:

- The role of Healthcare Providers (HCPs) in personalized medicine and its multi-faceted therapies

- Strategies for micro-targeting different healthcare personas, from primary care physicians to specialists

- Data privacy concerns surrounding patient information in cell & gene therapy

- The importance of Key Opinion Leaders (KOLs) in educating HCPs and patients

💡 Insights You'll Gain:

- How to align HCP journeys with personalized therapies and the intricacies of medical marketing

- A nuanced understanding of data privacy issues, particularly concerning the 'chain of custody' in cell & gene therapies

- How to differentiate marketing content for HCPs, KOLs, and patients effectively

🎧 Listen in as we dissect the patient journey, discuss the key differences between primary care and procedural physicians, and delve into how personalized medicine is revolutionizing the marketing playbook for healthcare and biopharma companies.

📊 Who Should Listen?

Healthcare Marketers
Pharma & Biotech Professionals
Data Analysts in Healthcare
Privacy Advocates
HCPs interested in the future of personalized medicine

Thank you for listening to OUTCOMES. Please find more healthcare and biopharma marketing thought leadership in the Insights section of our website and follow us on LinkedIn!